Adding targeted therapy to treatment extends lives of those with metastatic breast cancer
UCLA-led study evaluated use of drug combined with endocrine therapy in premenopausal womenCredit: UCLA Jonsson Comprehensive Cancer Center A UCLA-led ...
UCLA-led study evaluated use of drug combined with endocrine therapy in premenopausal womenCredit: UCLA Jonsson Comprehensive Cancer Center A UCLA-led ...
An international team of researchers has a plan to keep New Guinea's frogs safe from the species-destroying chytrid fungusCredit: Stephen ...
Teens experiencing weight-based bullying also reported poorer mental health and lower perceived health Hartford, CT - Weight-based victimization among sexual ...
Credit: University of British Columbia With summer break and longer days ahead, parents of young teens may be wondering whether ...
SALT LAKE CITY, UTAH - Today the New England Journal of Medicine published the first results of a phase III ...
The results of the ECOG-ACRIN Cancer Research Group's phase three trial, E2810, are being orally presented at the 2019 annual ...
-Credit: IEEE Researchers at Tokyo Institute of Technology (Tokyo Tech) and NEC Corporation, Japan, present a 39 GHz transceiver with ...
Findings from Arm H show that in a heavily pre-treated cohort of 17 distinct tumor types -- several rare -- ...
Iron-doping of the topological insulator Sb2Te3 results in useful electronic and magnetic propertiesCredit: FLEET/UOW Iron-doping of the topological insulator Sb2Te3 ...
Conference press materials now available Press materials are now available for Nutrition 2019, the flagship meeting of the American Society ...
Olaparib doubled progression-free survival for patients with BRCA mutationsCredit: Robert Kozloff, UChicago Treatment with the drug olaparib significantly reduced the ...
Nivolumab plus ipilimumab meet primary endpoint of MD Anderson NEOSTAR Phase II trialCredit: MD Anderson Cancer Center CHICAGO - Neoadjuvant, ...
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin (PC) to paclitaxel plus ifosfamide ...
Analyses of NRG Oncology/RTOG 9802 Suggests both IDH-mutant WHO-defined molecular subgroups of high-risk low-grade gliomas may benefit from the addition ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.